Literature DB >> 14173194

STANDARDIZATION OF ANTICOAGULANT TREATMENT: THE MANCHESTER REGIONAL THROMBOPLASTIN SCHEME.

L POLLER.   

Abstract

Keywords:  ANTICOAGULANTS; BRAIN; ENGLAND; PROTHROMBIN TIME; THROMBOPLASTIN; TISSUE EXTRACTS

Mesh:

Substances:

Year:  1964        PMID: 14173194      PMCID: PMC1816166          DOI: 10.1136/bmj.2.5408.565

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  1 in total

1.  Thrombotest. A new method for controlling anticoagulant therapy.

Authors:  P A OWREN
Journal:  Lancet       Date:  1959-11-07       Impact factor: 79.321

  1 in total
  9 in total

1.  National survey of value of plasma standards for anticoagulant therapy.

Authors:  L Poller; J M Thomson
Journal:  Br Med J       Date:  1968-04-13

2.  Improved control of long-term anticoagulant therapy.

Authors:  R D Eastham
Journal:  Br Med J       Date:  1968-05-11

3.  Control of anticoagulants.

Authors: 
Journal:  Br Med J       Date:  1969-10-18

4.  Platelet aggregation and strenuous exercise.

Authors:  L Poller; C M Priest; J M Thomson
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

5.  Laboratory control of anticoagulants.

Authors: 
Journal:  Br Med J       Date:  1966-01-29

6.  Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.

Authors:  R Biggs; K W Denson
Journal:  Br Med J       Date:  1967-01-14

7.  Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.

Authors:  L Poller; J M Thomson; C H Sear; W Thomas
Journal:  J Clin Pathol       Date:  1971-10       Impact factor: 3.411

8.  Coumarin therapy and platelet aggregation.

Authors:  L Poller; J M Thomson; C M Priest
Journal:  Br Med J       Date:  1969-02-22

9.  The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.

Authors:  E L Bailey; T A Harper; P H Pinkerton
Journal:  Can Med Assoc J       Date:  1971-11-20       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.